Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:30 pm Sale | 2024-09-30 | 13G | IO Biotech, Inc. IOBT | Stonepine Capital Management, LLC | 0 0.000% | -3,641,345 (Position Closed) | Filing History |
| 2024-09-17 9:01 pm Sale | 2024-09-13 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 5,823,584 8.500% | -1,075,000 (-15.58%) | Filing History |
| 2024-05-14 9:35 pm Sale | 2024-05-10 | 13G | IO Biotech, Inc. IOBT | Novo Holdings A/S | 6,898,584 10.100% | -658,809 (-8.72%) | Filing History |
| 2024-02-14 09:00 am Sale | 2023-12-31 | 13G | IO Biotech, Inc. IOBT | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -2,055,883 (Position Closed) | Filing History |
| 2024-02-13 9:34 pm Sale | 2024-02-09 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 7,557,393 11.100% | -658,809 (-8.02%) | Filing History |
| 2024-02-13 7:38 pm Sale | 2023-12-31 | 13G | IO Biotech, Inc. IOBT | BANK OF AMERICA CORP BAC | 1,844,185 2.800% | -10,000 (-0.54%) | Filing History |
| 2024-02-13 4:29 pm Sale | 2023-12-31 | 13G | IO Biotech, Inc. IOBT | Stonepine Capital Management, LLC | 3,641,345 5.400% | -309,271 (-7.83%) | Filing History |
| 2024-02-13 4:06 pm Sale | 2023-12-31 | 13G | IO Biotech, Inc. IOBT | HBM Healthcare Investments (Cayman) Ltd. | 3,944,492 6.000% | -1,578,947 (-28.59%) | Filing History |
| 2023-12-18 5:14 pm Purchase | 2023-08-09 | 13G | IO Biotech, Inc. IOBT | Samsara BioCapital, L.P. | 3,640,015 5.500% | 3,640,015 (New Position) | Filing History |
| 2023-09-07 10:36 am Purchase | 2023-08-31 | 13G | IO Biotech, Inc. IOBT | Kurma Partners | 12,253,230 17.180% | 12,253,230 (New Position) | Filing History |
| 2023-08-16 4:15 pm Purchase | 2023-08-07 | 13G | IO Biotech, Inc. IOBT | Stonepine Capital Management, LLC | 3,950,616 5.800% | 3,950,616 (New Position) | Filing History |
| 2023-08-15 3:15 pm Purchase | 2023-08-09 | 13G | IO Biotech, Inc. IOBT | HBM Healthcare Investments (Cayman) Ltd. | 5,523,439 8.190% | 1,524,008 (+38.11%) | Filing History |
| 2023-08-14 3:45 pm Purchase | 2023-08-09 | 13G | IO Biotech, Inc. IOBT | HBM Healthcare Investments (Cayman) Ltd. | 3,999,431 6.100% | 1,578,947 (+65.23%) | Filing History |
| 2023-08-14 3:45 pm Purchase | 2023-08-09 | 13D | IO Biotech, Inc. IOBT | Lundbeckfond Invest A/S | 21,851,920 29.600% | 15,802,468 (+261.22%) | Filing History |
| 2023-08-11 4:40 pm Purchase | 2023-08-09 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 8,216,202 12.000% | 4,938,270 (+150.65%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | IO Biotech, Inc. IOBT | RA CAPITAL MANAGEMENT L.P. | 1,127,260 3.900% | -730,495 (-39.32%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | IO Biotech, Inc. IOBT | PFM Health Sciences LP | 507,640 1.800% | -1,002,496 (-66.38%) | Filing History |
| 2023-02-14 08:11 am Purchase | 2022-12-31 | 13G | IO Biotech, Inc. IOBT | BANK OF AMERICA CORP BAC | 1,854,185 6.400% | 1,854,185 (New Position) | Filing History |
| 2022-09-30 4:51 pm Unchanged | 2022-09-27 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 3,277,932 11.400% | 0 (Unchanged) | Filing History |
| 2022-05-26 11:57 am Unchanged | 2022-05-25 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 3,277,932 11.300% | 0 (Unchanged) | Filing History |